Work

Efficacy and Safety of Rivaroxaban Versus Warfarin in Patients Taking Nondihydropyridine Calcium Channel Blockers for Atrial Fibrillation (from the ROCKET AF Trial)

Year: 2017

Type: article

Source: The American Journal of Cardiology

DOI: 10.1016/j.amjcard.2017.05.026

Authors: Jeffrey B. Washam, Anne S. Hellkamp, Yuliya Lokhnygina, Jonathan P. Piccini, Scott D. Berkowitz, Christopher C. Nessel, Richard C. Becker, Günter Breithardt, Keith A.A. Fox, Jonathan L. Halperin, Graeme J. Hankey, Kenneth W. Mahaffey, Daniel E. Singer, Manesh R. Patel

Institutions: Duke Medical Center, Duke Clinical Research Institute, Bayer (United States), Janssen Research & Development (United States), University of Cincinnati, University Hospital Münster, Edinburgh Royal Infirmary, University of Edinburgh, Icahn School of Medicine at Mount Sinai, The University of Western Australia, Stanford Medicine, Stanford University, Harvard University, Massachusetts General Hospital

Language: English

Topic: Atrial Fibrillation Management and Outcomes

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Duke Clinical Research Institute

OpenAlex ID: W2618250458

FWCI: 3.639

Cites: 13

Cited by: 44

Related to: 10